Table 2 Comparison between COVID-19 patients with AKI (yes/no—hemodialysis)

 Diabetes

25 (73.5%)

8 (14.0%)

5.2390 (2.1250–12.9162)

< 0.001

 Hypertension

27 (79.4%)

16 (28.0%)

2.8290 (1.3361–5.9901)

0.006

 Cardiac disease

8 (23.5%)

3 (5.2%)

4.4706 (1.1099–18.0070)

0.0351

 Asthma

1 (2.9%)

1 (1.7%)

1.6765 (0.1015–27.6852)

0.7180

 Liver disease

4 (11.7%)

2 (3.5%)

3.3529 (0.5828–19.2898)

0.1753

 Cancer

7 (20.6%)

4 (7.0%)

2.9338 (0.7997–10.7633)

0.1046

 Fever

32 (94.1%)

46 (80.7%)

1.1662 (0.6276–2.1672)

0.6267

 Cough

30 (88.2%)

36 (82.5%)

1.3971 (0.7335–2.6610)

0.3091

 Dyspnea

34 (100%)

33 (57.9%)

1.7273 (0.9106–3.2762)

0.0942

 Sore throat

5 (14.7%)

12 (21.0%)

0.6985 (0.2265–2.1547)

0.5324

 Diarrhea

7 (20.5%)

10 (17.5%)

1.1735 (0.4086–3.3709)

0.7663

 Fatigue

25 (73.5%)

12 (21.0%)

3.4926 (1.5556–7.8419)

0.0024

 Abdominal pain

6 (17.6%)

2 (3.5%)

5.0294 (0.9604–26.3386)

0.0559

 Myalgia

8 (23.5%)

8 (14.0%)

1.6765 (0.5762–4.8781)

0.3430

 HB%, g/dL

10.5 (10–11.0)

12.2 (11.2–13.2)

1.3971 (0.5454–3.5785)

0.4859

 WBCs, ×10³/μ L

11.7 (8.9–14.5)

7.3 (5.7–8.8)

2.6345 (0.9326–7.4421)

0.0675

 PLT, ×10³/μ L

224.9 (210–239.8)

164.5 (107–222)

2.2861 (1.4291–3.6571)

0.006

 CRP, mg/dL

1017 (760–1275)

626.5 (566–687)

2.7193 (1.7579–4.2063)

< 0.001

 B. urea, mg/dL

137.5 (75–200)

60 (46–74)

3.8279 (2.2713–6.4514)

< 0.001

 S. creatinine, mg/dL

8.9 (4.1–13.7)

2.65 (1.3–4.0)

5.0294 (1.2730–19.8710)

0.0212

 D-dimer, mg/mL

1495.5 (1011–1980)

1445.7 (891.5–2000)

1.7344 (1.1273–2.6685)

0.0122

 Home

0.00

13 (22.8%)

0.0617 (0.0036–1.0715)

0.0558

 Hospital

12 (35.3%)

37 (64.9%)

0.5437 (0.2499–1.1830)

0.1245

 ICU

22 (64.7%)

7 (12.3%)

5.2689 (2.0363–13.6332)

< 0.001

 Cure

21 (61.7%)

56 (98.2%)

0.6287 (0.3258–1.2130)

0.1663

 Death

13 (38.3%)

1 (1.8%)

21.7941 (2.7286–174.0770)

0.0037